News

Stonehaven is proud to announce that Mark Sullivan, CFA, a Stonehaven partner, has been appointed Co-Chair of the NYSSA Alternative Investments Interest Group.  As Co-Chair, Mark will work to:

  • Create events and forums, focused on alternative investments, that are valued by the NYSSA’s membership base,
  • Unify a strong and valuable network of professional peers, and
  • Establish voice of a well-positioned constituency who share ideals in regard to professionalism and integrity.

The New York Society of Security Analysts (NYSSA) was founded by a group of professionals that included Benjamin Graham, the “father of securities analysis” and one of the most influential men in the history of finance. Through generations of investment professionals NYSSA remains steady as a leading forum for the investment community since 1937.  Today, with almost 9,000 members, NYSSA is one of the largest of the more than 142 societies worldwide that comprise CFA Institute.  The mission of the NYSSA Alternative Investments Interest Group is to provide a forum for the discussion and analysis of nontraditional investment approaches, including all forms of hedge funds, funds of funds, private equity, structured products, institutional real estate, and other investments.   Mark will Co-Chair the group alongside, Steven Bloom, CFA, an independent real estate specialist.


About Stonehaven, LLC
Stonehaven is an industry leading global placement agent focused on hedge funds, private equity, real estate, venture capital, private placements, and long‐only strategies.  Stonehaven’s platform serves as a nexus between select investment opportunities and the institutional investment community with a talented capital raising team and robust infrastructure. The Firm’s dynamic structure fosters an ever‐ evolving stable of distinctive managers to match the demand across the diverse investor community. Founded in 2001 by CEO David Frank, the Firm is entirely management owned, giving it complete independence to continue pursuing its entrepreneurial approach while maintaining the highest ethical and regulatory standards.